• Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of "Hold" from Analysts

    Источник: Buzz FX / 23 сен 2024 04:01:10   America/Chicago


    Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of "Hold" from Analysts Written by MarketBeat September 23, 2024 Share Link copied to clipboard. Revance Therapeutics, Inc. ( NASDAQ:RVNC - Get Free Report ) has earned an ave
    Read more...
Опубликовать